Logo image of TCRX

TSCAN THERAPEUTICS INC (TCRX) Stock Earnings & Estimates

NASDAQ:TCRX - US89854M1018 - Common Stock

1.75 USD
-0.05 (-2.78%)
Last: 9/2/2025, 8:00:01 PM
1.79 USD
+0.04 (+2.29%)
After Hours: 9/2/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TCRX revenue by date.TCRX revenue by date.
13.54M
33.53%
21.049M
55.46%
2.816M
-86.62%
10.002M
255.18%
8.588M
-14.14%
57.755M
572.51%
54.845M
-5.04%
114.54M
108.84%
198.69M
73.47%
396.45M
99.53%
494.55M
24.74%
EBITDA
YoY % growth
TCRX ebitda by date.TCRX ebitda by date.
-61.5M
-35.73%
-88.097M
-43.25%
-130.713M
-48.37%
-142.107M
-8.72%
-163.739M
-15.22%
-41.935M
74.39%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
TCRX ebit by date.TCRX ebit by date.
-66.64M
-37.01%
-93.458M
-40.24%
-134.821M
-44.26%
-157.739M
-17.00%
-169.757M
-7.62%
-145.023M
14.57%
-167.687M
-15.63%
-126.522M
24.55%
-54.81M
56.68%
109.78M
300.29%
168.29M
53.30%
Operating Margin
TCRX operating margin by date.TCRX operating margin by date.
-492.17%-444.00%-4,787.68%-1,577.07%-1,976.68%-251.10%-305.75%-110.46%-27.59%27.69%34.03%
EPS
YoY % growth
TCRX eps by date.TCRX eps by date.
-2.75
59.08%
-1.89
31.27%
-1.15
39.15%
-1.16
-0.78%
-1.22
-5.59%
-0.87
28.83%
-1.00
-14.37%
-0.69
31.06%
-0.24
65.35%
0.62
361.47%
0.95
52.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.31
-22.22%
-0.29
2.66%
-0.27
-5.14%
-0.30
-5.52%
-0.30
1.97%
-0.29
-0.13%
Revenue
Q2Q % growth
2.02M
92.56%
1.765M
165.41%
2.339M
7.74%
1.489M
-51.59%
1.319M
-34.70%
1.319M
-25.27%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-40.914M
-25.42%
-42.7M
-16.31%
-41.616M
-14.80%
-42.636M
-10.30%
-43.784M
-7.01%
-44.549M
-4.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.28 -0.290.012.17%
Q1 2025
Q2Q % growth
-0.26
18.75%
-0.290.0310.87%
Q4 2024
Q2Q % growth
-0.30
-42.86%
-0.28-0.02-7.46%
Q3 2024
Q2Q % growth
-0.25
-4.17%
-0.290.0414.81%
Q2 2024
Q2Q % growth
-0.28
45.10%
-0.290.012.95%
Q1 2024
Q2Q % growth
-0.32
65.59%
-0.26-0.06-22.31%
Q4 2023
Q2Q % growth
-0.21
73.08%
-0.300.0929.01%
Q3 2023
Q2Q % growth
-0.24
64.18%
-0.460.2247.94%
Q2 2023
Q2Q % growth
-0.51
19.05%
-0.790.2835.65%
Q1 2023
Q2Q % growth
-0.93
-38.81%
-0.75-0.18-23.63%
Q4 2022
Q2Q % growth
-0.78
-105.26%
-0.72-0.06-8.85%
Q3 2022
Q2Q % growth
-0.67
16.25%
-0.730.068.77%
Q2 2022
Q2Q % growth
-0.63
91.81%
-0.760.1317.37%
Q1 2022
Q2Q % growth
-0.67 -0.740.079.40%
Q4 2021
Q2Q % growth
-0.38 -0.750.3749.11%
Q3 2021
Q2Q % growth
-0.80 -0.65-0.15-22.55%
Q2 2021
Q2Q % growth
-7.69 -2.93-4.76-162.39%
TCRX Yearly EPS VS EstimatesTCRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -2 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
3.076M
473.88%
1.433M1.643M114.65%
Q1 2025
Q2Q % growth
2.171M
283.57%
1.127M1.044M92.64%
Q4 2024
Q2Q % growth
665K
-90.78%
1.377M-712K-51.71%
Q3 2024
Q2Q % growth
1.049M
-73.01%
1.082M-33K-3.05%
Q2 2024
Q2Q % growth
536K
-82.97%
2.467M-1.931M-78.27%
Q1 2024
Q2Q % growth
566K
-91.68%
4.055M-3.489M-86.04%
Q4 2023
Q2Q % growth
7.211M
132.61%
3.407M3.804M111.65%
Q3 2023
Q2Q % growth
3.887M
15.68%
4.17M-283K-6.79%
Q2 2023
Q2Q % growth
3.148M
-22.46%
4.111M-963K-23.42%
Q1 2023
Q2Q % growth
6.803M
125.26%
4.49M2.313M51.51%
Q4 2022
Q2Q % growth
3.1M
8.77%
3.9M-800K-20.51%
Q3 2022
Q2Q % growth
3.36M
39.42%
3.772M-412K-10.92%
Q2 2022
Q2Q % growth
4.06M
42.46%
3.063M997K32.55%
Q1 2022
Q2Q % growth
3.02M
48.77%
2.618M402K15.36%
Q4 2021
Q2Q % growth
2.85M
256.25%
3.289M-439K-13.35%
Q3 2021
Q2Q % growth
2.41M
731.03%
2.478M-68K-2.74%
Q2 2021
Q2Q % growth
2.85M 1.088M1.762M161.95%
TCRX Yearly Revenue VS EstimatesTCRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.04% -2.42% -1.41% -1.41%
Revenue31.6% 44.7% 37.03% 110.35%